On-Demand Cold Chain Webinars

31. Data Management Transitions And Their Impact On Advanced Therapy Supply Chains 2/16/2022

    Learn about network transitions, the challenges with technology changes, and how you can ensure the certainty of global coverage and data fidelity for your cell and gene therapy shipments.

32. Decentralized Trials: How To Develop A Flexible Supply Chain 1/20/2022

    Explore the opportunities to optimize your supply chain strategy and facilitate direct-to-site, direct-to-patient and hybrid services utilizing a global GMP depot network.

33. Cryopreservation's Impact On Cell Therapy Consistency, Quality 1/12/2022

    Explore the underpinning mechanisms driving freeze/thaw applications and their implications across varied drug product containment configurations and volumes.

34. SUS Design For Cryogenic, Cold Temperature Operations 6/2/2021

    Learn more about the uncertainties and complexities encountered when expanding the application of single-use technologies (SUT) in cryogenic bioprocesses.

35. Validation Of Integrated Cryogenic Systems For Cell Therapy Manufacturing 4/13/2021

    Amittha Wickrema, Ph.D., Professor of Medicine, Director, Advanced Cellular Therapeutics Facility, University of Chicago, reviews the cold chain workflow from start to finish for a cellular therapy product.

36. Cell Therapy Logistics: Exploring The Last 100m 4/13/2021

    If advanced therapies are to be scaled, their management at hospital sites must be scalable. How can we remove complexity — making life easier for couriers, manufacturers, and hospitals — and create a seamless supply chain?

37. Achieving A Flexible, Integrated And Sustainable Cryogenic Cold Chain Ecosystem 4/13/2021

    During this discussion, panelists examine the cell and gene therapy solutions that have been designed to overcome challenges in the cryogenic cold chain ecosystem.

38. Cell Therapy Logistics: Advanced Therapy Treatment Case Study 8/4/2020

    This case study describes work the establishment and testing of a cryogenic logistics pathway for an allogeneic Advanced Therapy Medicinal Product (ATMP).

39. Risk Mitigation For Single-Use Cold Chain Distribution 7/7/2020

    Study data shows the utility of low temperature suitable materials and packaging,  sensors for monitoring shipments, and qualification and evaluation through simulated standards and real-world transit.

40. Essential Up-Front Planning For Your Clinical Trial

    Early planning mitigates risk by avoiding stock outs and study delays, minimizing waste with optimized inventory, and forecasting demand to facilitate robust supply planning.